RxDoctor Payments Data

Kurt Nelson, MD

Otolaryngology · Tupelo, MSNPI 1821330168

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Acclarent, Inc at 24.2% of the total.

$1,581in general payments, 2019–2025

Across 41 payments — averaging $38.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$382
  • Inspire Medical Systems, Inc.$330
  • Aerin Medical Inc.$218
  • Sanofi$132
  • Stryker$99
  • Cumberland Pharmaceuticals, Inc.$83
  • plus $337 from 11 others

What the payments were for

  • Food & beverage$1,54798%
  • Education$342%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,581 in reported general payments places this provider in the 55th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$295,857
Medicare patients
690
Services billed
1,942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl215$6,478
Ipratropium Bromide189$4,613
Fluticasone Propionate277$2,810
Pantoprazole Sodium111$1,097
Omeprazole114$1,062
Ofloxacin29$1,014
Betamethasone Valerate46$850
Tobramycin-DexamethasoneTobramycin/Dexamethasone17$828
Montelukast Sodium137$711
Ondansetron OdtOndansetron38$387
Mupirocin51$373
Nystatin19$281
Fluconazole19$266
Gabapentin18$216
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$196

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →